Linda Lennox | VP, IR |
Bill Heiden | President and CEO |
Nik Grund | Chief Commercial Officer |
Ted Myles | CFO |
Jessica Fye | JP Morgan |
Kyung Yang | Jefferies |
David Buck | B. Riley FBR |
Sriker Nadipuram | Barclays |
Morgan McCarthy | Needham |
Ken Trbovich | Janney |
William Maughan | Cowen |
Good morning. My name is Lori, and I will be your conference operator today. At this time, I would like to welcome everyone, to the AMAG Pharmaceuticals Second Quarter 2018 Earnings Call. [Operator Instructions]. It is now my pleasure to turn today’s call over to Ms.